GRIK2_HUMAN - dbPTM
GRIK2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID GRIK2_HUMAN
UniProt AC Q13002
Protein Name Glutamate receptor ionotropic, kainate 2
Gene Name GRIK2
Organism Homo sapiens (Human).
Sequence Length 908
Subcellular Localization Cell membrane
Multi-pass membrane protein. Cell junction, synapse, postsynaptic cell membrane
Multi-pass membrane protein.
Protein Description Ionotropic glutamate receptor. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. [PubMed: 28180184 May be involved in the transmission of light information from the retina to the hypothalamus. Modulates cell surface expression of NETO2 (By similarity]
Protein Sequence MKIIFPILSNPVFRRTVKLLLCLLWIGYSQGTTHVLRFGGIFEYVESGPMGAEELAFRFAVNTINRNRTLLPNTTLTYDTQKINLYDSFEASKKACDQLSLGVAAIFGPSHSSSANAVQSICNALGVPHIQTRWKHQVSDNKDSFYVSLYPDFSSLSRAILDLVQFFKWKTVTVVYDDSTGLIRLQELIKAPSRYNLRLKIRQLPADTKDAKPLLKEMKRGKEFHVIFDCSHEMAAGILKQALAMGMMTEYYHYIFTTLDLFALDVEPYRYSGVNMTGFRILNTENTQVSSIIEKWSMERLQAPPKPDSGLLDGFMTTDAALMYDAVHVVSVAVQQFPQMTVSSLQCNRHKPWRFGTRFMSLIKEAHWEGLTGRITFNKTNGLRTDFDLDVISLKEEGLEKIGTWDPASGLNMTESQKGKPANITDSLSNRSLIVTTILEEPYVLFKKSDKPLYGNDRFEGYCIDLLRELSTILGFTYEIRLVEDGKYGAQDDANGQWNGMVRELIDHKADLAVAPLAITYVREKVIDFSKPFMTLGISILYRKPNGTNPGVFSFLNPLSPDIWMYILLAYLGVSCVLFVIARFSPYEWYNPHPCNPDSDVVENNFTLLNSFWFGVGALMQQGSELMPKALSTRIVGGIWWFFTLIIISSYTANLAAFLTVERMESPIDSADDLAKQTKIEYGAVEDGATMTFFKKSKISTYDKMWAFMSSRRQSVLVKSNEEGIQRVLTSDYAFLMESTTIEFVTQRNCNLTQIGGLIDSKGYGVGTPMGSPYRDKITIAILQLQEEGKLHMMKEKWWRGNGCPEEESKEASALGVQNIGGIFIVLAAGLVLSVFVAVGEFLYKSKKNAQLEKRSFCSAMVEELRMSLKCQRRLKHKPQAPVIVKTEEVINMHTFNDRRLPGKETMA
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
67N-linked_GlycosylationAVNTINRNRTLLPNT
HHHHCCCCCCCCCCC
36.48UniProtKB CARBOHYD
73N-linked_GlycosylationRNRTLLPNTTLTYDT
CCCCCCCCCEEEECC
45.74UniProtKB CARBOHYD
171PhosphorylationVQFFKWKTVTVVYDD
HHHHCCCEEEEEEEC
21.94-
173PhosphorylationFFKWKTVTVVYDDST
HHCCCEEEEEEECCC
14.97-
193PhosphorylationQELIKAPSRYNLRLK
HHHHHCCCCCCCEEE
52.8624719451
195PhosphorylationLIKAPSRYNLRLKIR
HHHCCCCCCCEEEEE
23.9224719451
209AcetylationRQLPADTKDAKPLLK
EECCCCCCCCHHHHH
57.127971985
212AcetylationPADTKDAKPLLKEMK
CCCCCCCHHHHHHHH
46.467632029
275N-linked_GlycosylationPYRYSGVNMTGFRIL
CCCCCCCCCCCEEEE
26.31UniProtKB CARBOHYD
361PhosphorylationRFGTRFMSLIKEAHW
CCHHHHHHHHHHHCC
25.0024719451
372PhosphorylationEAHWEGLTGRITFNK
HHCCCCCCCEEEEEC
34.9626074081
376PhosphorylationEGLTGRITFNKTNGL
CCCCCEEEEECCCCC
21.5726074081
378N-linked_GlycosylationLTGRITFNKTNGLRT
CCCEEEEECCCCCCC
41.41UniProtKB CARBOHYD
380PhosphorylationGRITFNKTNGLRTDF
CEEEEECCCCCCCCC
35.3126074081
385PhosphorylationNKTNGLRTDFDLDVI
ECCCCCCCCCEEEEE
46.1726074081
393PhosphorylationDFDLDVISLKEEGLE
CCEEEEEEECHHHHH
32.9824719451
395UbiquitinationDLDVISLKEEGLEKI
EEEEEEECHHHHHHC
47.10-
404PhosphorylationEGLEKIGTWDPASGL
HHHHHCCCCCCCCCC
30.1223663014
409PhosphorylationIGTWDPASGLNMTES
CCCCCCCCCCCCCHH
49.5623663014
412N-linked_GlycosylationWDPASGLNMTESQKG
CCCCCCCCCCHHHCC
38.56UniProtKB CARBOHYD
414PhosphorylationPASGLNMTESQKGKP
CCCCCCCCHHHCCCC
31.2623663014
416PhosphorylationSGLNMTESQKGKPAN
CCCCCCHHHCCCCCC
28.2023663014
423N-linked_GlycosylationSQKGKPANITDSLSN
HHCCCCCCCCHHCCC
46.34UniProtKB CARBOHYD
425PhosphorylationKGKPANITDSLSNRS
CCCCCCCCHHCCCCC
21.24-
429PhosphorylationANITDSLSNRSLIVT
CCCCHHCCCCCEEEE
33.86-
430N-linked_GlycosylationNITDSLSNRSLIVTT
CCCHHCCCCCEEEEE
42.74UniProtKB CARBOHYD
437PhosphorylationNRSLIVTTILEEPYV
CCCEEEEEECCCCEE
16.81-
546N-linked_GlycosylationSILYRKPNGTNPGVF
EEEEECCCCCCCCHH
73.328188697
546N-linked_GlycosylationSILYRKPNGTNPGVF
EEEEECCCCCCCCHH
73.32UniProtKB CARBOHYD
590PhosphorylationRFSPYEWYNPHPCNP
CCCCCCCCCCCCCCC
13.58-
666PhosphorylationLTVERMESPIDSADD
HCHHCCCCCCCCHHH
20.15-
670PhosphorylationRMESPIDSADDLAKQ
CCCCCCCCHHHHHHH
34.03-
682PhosphorylationAKQTKIEYGAVEDGA
HHHHCCEEECCCCCC
17.54-
697PhosphorylationTMTFFKKSKISTYDK
EEEEEEHHCCCHHHH
35.498382377
700PhosphorylationFFKKSKISTYDKMWA
EEEHHCCCHHHHHHH
25.34-
702PhosphorylationKKSKISTYDKMWAFM
EHHCCCHHHHHHHHH
13.53-
715PhosphorylationFMSSRRQSVLVKSNE
HHHHCCCEEEEECCH
18.668094892
751N-linked_GlycosylationFVTQRNCNLTQIGGL
EECCCCCCEEEECCE
50.07-
751N-linked_GlycosylationFVTQRNCNLTQIGGL
EECCCCCCEEEECCE
50.078163463
834PhosphorylationLAAGLVLSVFVAVGE
HHHHHHHHHHHHHHH
13.16-
846PhosphorylationVGEFLYKSKKNAQLE
HHHHHHHCCCCHHHH
34.9922808340
847AcetylationGEFLYKSKKNAQLEK
HHHHHHCCCCHHHHH
45.9926210075
848AcetylationEFLYKSKKNAQLEKR
HHHHHCCCCHHHHHH
65.6826210075
859PhosphorylationLEKRSFCSAMVEELR
HHHHHHHHHHHHHHH
19.8628555341
868PhosphorylationMVEELRMSLKCQRRL
HHHHHHHHHHHHHHH
20.4522808340
886SumoylationPQAPVIVKTEEVINM
CCCCEEEECHHEEEC
38.8122808340
886SumoylationPQAPVIVKTEEVINM
CCCCEEEECHHEEEC
38.81-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
590YPhosphorylationKinaseSRCP12931
PSP
697SPhosphorylationKinasePKA-FAMILY-GPS
697SPhosphorylationKinasePKA_GROUP-PhosphoELM
715SPhosphorylationKinasePKA-FAMILY-GPS
715SPhosphorylationKinasePKA_GROUP-PhosphoELM
846SPhosphorylationKinasePKC-Uniprot
868SPhosphorylationKinasePRKCAP17252
GPS
868SPhosphorylationKinasePKC-Uniprot
-KUbiquitinationE3 ubiquitin ligaseKLHL17Q6TDP4
PMID:17062563

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
868SPhosphorylation

22808340
868SSumoylation

22808340

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of GRIK2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SDCB1_HUMANSDCBPphysical
12597860
PICK1_HUMANPICK1physical
12597860
DLG4_HUMANDLG4physical
12597860
GRIP1_HUMANGRIP1physical
12597860
GRID2_HUMANGRID2physical
12573530
DLG4_HUMANDLG4physical
9808460
DLG3_HUMANDLG3physical
9808460
DLG1_HUMANDLG1physical
9808460
GRIK5_HUMANGRIK5physical
8288598
GRIA1_HUMANGRIA1physical
8288598
GRIA2_HUMANGRIA2physical
8288598
GRIK5_HUMANGRIK5physical
9466455
PICK1_HUMANPICK1physical
18692513
TRI25_HUMANTRIM25physical
21988832
GRIK5_HUMANGRIK5physical
15583001

Drug and Disease Associations
Kegg Disease
H00768 Nonsyndromic autosomal recessive mental retardation (NS-ARMR)
OMIM Disease
611092Mental retardation, autosomal recessive 6 (MRT6)
Kegg Drug
D00537 Topiramate (JAN/USAN/INN); Topamax (TN); Trokendi xr (TN)
D02546 Kainic acid hydrate (JP16); Digenin (TN)
D06656 Tezampanel (USAN); Tezampanel hydrate
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of GRIK2_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP